Mark W. Lingen to Radiopharmaceuticals
This is a "connection" page, showing publications Mark W. Lingen has written about Radiopharmaceuticals.
Connection Strength
0.118
-
Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy. Cancer Lett. 2015 Apr 10; 359(2):269-74.
Score: 0.118